Date | Name | Activity | Value |
---|---|---|---|
Sep 11, 2024 | William John Sibold President & Ceo,director | xxxxxxxxxxxxx | $1551490 |
Jun 18, 2024 | Robert E. Waltermire Svp, Chief Pharma Dev | xxxxxxxxxxxxx | $532000 |
Jun 14, 2024 | Robert E. Waltermire Svp, Chief Pharma Dev | xxxxxxxxxxxxx | $570000 |
May 23, 2024 | Robert E. Waltermire Svp, Chief Pharma Dev | xxxxxxxxxxxxx | $239668 |
Date | Firm | Activity | Value |
---|---|---|---|
Jun 30, 2024 | xxxxxxxxxxxxx | $980560 | |
Jun 30, 2024 | xxxxxxxxxxxxx | $10751700 | |
Jun 30, 2024 | xxxxxxxxxxxxx | $38748649 | |
Jun 30, 2024 | xxxxxxxxxxxxx | $74130336 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
2,149,555 | Insider | 9.90% | 462,906,669 | |
1,974,590 | Institution | 9.09% | 425,227,957 | |
1,850,000 | Institution | 8.52% | 398,397,500 | |
1,794,831 | Insider | 8.27% | 386,516,856 | |
1,737,799 | Institution | 8.00% | 374,235,015 | |
1,713,438 | Institution | 7.89% | 368,988,873 | |
1,596,833 | Institution | 7.35% | 343,877,987 | |
1,114,539 | Insider | 5.13% | 240,015,974 | |
841,989 | Insider | 3.88% | 181,322,331 | |
809,437 | Institution | 3.73% | 174,312,258 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
1,713,438 | Institution | 7.89% | 368,988,873 | |
1,596,833 | Institution | 7.35% | 343,877,987 | |
329,178 | Institution | 1.52% | 70,888,482 | |
293,510 | Institution | 1.35% | 63,207,379 | |
264,359 | Institution | 1.22% | 56,929,711 | |
214,256 | Institution | 0.99% | 46,140,030 | |
195,668 | Institution | 0.90% | 42,137,104 | |
194,448 | Institution | 0.90% | 41,874,377 | |
97,158 | Institution | 0.45% | 20,922,975 | |
91,124 | Institution | 0.42% | 19,623,553 |
Holder | # of Shares | Type | % Holding | Value |
---|